药品名称KEFUROX
申请号062592产品号001
活性成分CEFUROXIME SODIUM市场状态停止上市
剂型或给药途径INJECTABLE;INTRAVENOUS规格EQ 750MG BASE/VIAL
治疗等效代码参比药物
批准日期1986/01/10申请机构ELI LILLY AND CO
化学类型审评分类
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
062592026AP2002/11/12Labeling
062592025AP2002/09/30Package Change
062592024AP2002/11/12Labeling
062592023AP2002/09/04Microbiology
062592022AP2002/06/24Microbiology
062592021AP2001/09/05Control Supplement
062592020AP2001/01/22Labeling
062592019AP2001/01/22Chemistry
062592018AP2001/01/22Chemistry
062592017AP2001/01/22Chemistry
062592015AP1996/08/15Chemistry
062592014AP1997/01/23Labeling
062592013AP1997/01/13Chemistry
062592012AP1997/01/23Chemistry
062592010AP1992/10/30Chemistry
062592009AP1992/06/12Labeling
062592005AP1992/06/12Chemistry in Effect
062592001AP1986/07/21Chemistry
062592000AP1986/01/10Approval